SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-008669
Filing Date
2020-01-30
Accepted
2020-01-30 16:03:32
Documents
7
Period of Report
2020-01-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm206058-4_8k.htm 8-K 25465
2 EXHIBIT 1.1 tm206058d4_ex1-1.htm EX-1.1 205197
3 EXHIBIT 5.1 tm206058d4_ex5-1.htm EX-5.1 13680
4 EXHIBIT 99.1 tm206058d4_ex99-1.htm EX-99.1 9579
5 GRAPHIC tm206058d4_ex5-1img001.jpg GRAPHIC 3318
6 GRAPHIC tm206058d4_ex5-1img002.jpg GRAPHIC 22552
7 GRAPHIC tm206058d4_ex5-1img003.jpg GRAPHIC 8338
  Complete submission text file 0001104659-20-008669.txt   302743
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 20561402
SIC: 2834 Pharmaceutical Preparations